文献速递血液净化与透析

血液透析住院与再入院:支付改革的影响

Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform.
PubMed 文献 · Am J Kidney Dis · 2016-11-14

BACKGROUND: In 2004, the Centers for Medicare & Medicaid Services changed reimbursement for physicians and advanced practitioners caring for patients receiving hemodialysis from a capitated to a tiered fee-for-service system, encouraging increased face-to-face visits.…

要点

  • 2004年美国医保报销改革鼓励增加血液透析患者面对面访视。
  • 改革后全因住院和30天再入院无显著变化。

核心结论

  • 旨在鼓励增加门诊血液透析期间访视的医保报销政策可能成本高昂。
  • 该政策与液体过载住院和再入院减少相关,但对全因住院或再入院无影响。

研究设计与样本

  • 回顾性队列中断时间序列研究,使用美国医疗保险受益人在报销改革前后各2年的数据。
  • 利用已发表数据估算与更频繁访视相关的年度经济成本范围。

主要发现

  • 全因住院或再入院无显著变化。
  • 液体过载住院和再入院略有减少。

局限性

  • 由于关于报销改革后提供者花费额外时间访视患者的信息有限,只能检查与改革相关的潜在经济成本范围。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2004, the Centers for Medicare & Medicaid Services changed reimbursement for physicians and advanced practitioners caring for patients receiving hemodialysis from a capitated to a tiered fee-for-service system, encouraging increased face-to-face visits. This early version of a pay-for-performance initiative targeted a care process: more frequent provider visits in hemodialysis. Although more frequent provider visits in hemodialysis are associated with fewer hospitalizations and rehospitalizations, it is unknown whether encouraging more frequent visits through reimbursement policy also yielded these benefits. STUDY DESIGN: We used a retrospective cohort interrupted time-series study design to examine whether the 2004 nephrologist reimbursement reform led to reduced hospitalizations and rehospitalizations. We also used published data to estimate a range of annual economic costs associated with more frequent visits. SETTING & PARTICIPANTS: Medicare beneficiaries in the United States receiving hemodialysis in the 2 years prior to and following reimbursement reform. PREDICTOR: The 2 years following nephrologist reimbursement reform. OUTCOMES: Odds of hospitalization and 30-day hospital readmission for all causes and fluid overload; US dollars. RESULTS: We found no significant change in all-cause hospitalization or rehospitalization and slight reductions in fluid overload hospitalization and rehospitalization following reimbursement reform; the estimated economic cost associated with additional visits ranged from $13 to $87 million per year, depending on who (physicians or advanced practitioners) spent additional time visiting patients and how much additional effort was involved. LIMITATIONS: Due to limited information about how much additional time providers spent seeing patients after reimbursement reform, we could only examine a range of potential economic costs associated with the reform. CONCLUSIONS: A Medicare reimbursement policy designed to encourage more frequent visits during outpatient hemodialysis may have been costly. The policy was associated with fewer hospitalizations and rehospitalizations for fluid overload, but had no effect on all-cause hospitalizations or rehospitalizations.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Erickson KF, Winkelmayer WC, Chertow GM, et al. Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform. Am J Kidney Dis. 2016. PMID: 27856087. doi:10.1053/j.ajkd.2016.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。